206 related articles for article (PubMed ID: 32951572)
1. Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China.
Xia Y; Li X; Sun W
Curr Gene Ther; 2020; 20(2):127-141. PubMed ID: 32951572
[TBL] [Abstract][Full Text] [Related]
2. The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic.
Zhang WW; Li L; Li D; Liu J; Li X; Li W; Xu X; Zhang MJ; Chandler LA; Lin H; Hu A; Xu W; Lam DM
Hum Gene Ther; 2018 Feb; 29(2):160-179. PubMed ID: 29338444
[TBL] [Abstract][Full Text] [Related]
3. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study of TP53 Gene Therapy.
Xia Y; Du Z; Wang X; Li X
Hum Gene Ther; 2018 Feb; 29(2):242-250. PubMed ID: 29281902
[TBL] [Abstract][Full Text] [Related]
5. Key points of basic theories and clinical practice in rAd-p53 ( Gendicine ™) gene therapy for solid malignant tumors.
Li Y; Li B; Li CJ; Li LJ
Expert Opin Biol Ther; 2015 Mar; 15(3):437-54. PubMed ID: 25496374
[TBL] [Abstract][Full Text] [Related]
6. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Zhu GY; Xu B
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):426-8. PubMed ID: 16188130
[TBL] [Abstract][Full Text] [Related]
7. Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers.
Peng Z
Hum Gene Ther; 2005 Sep; 16(9):1016-27. PubMed ID: 16149900
[No Abstract] [Full Text] [Related]
8. Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology.
Qi L; Li G; Li P; Wang H; Fang X; He T; Li J
Genes Dis; 2024 Jul; 11(4):101155. PubMed ID: 38523676
[TBL] [Abstract][Full Text] [Related]
9. Advances in adenovirus-mediated p53 cancer gene therapy.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
[TBL] [Abstract][Full Text] [Related]
10. INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
BioDrugs; 2003; 17(3):216-22. PubMed ID: 12749760
[TBL] [Abstract][Full Text] [Related]
11. Investigation on the Genomic Characterization of Uterine Sarcoma for rAd-
Xia Y; Wang L; Ma X; Li X
Hum Gene Ther; 2020 Aug; 31(15-16):881-890. PubMed ID: 32013587
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated wild-type p53 gene transfer in combination with bronchial arterial infusion for treatment of advanced non-small-cell lung cancer, one year follow-up.
Guan YS; Liu Y; Zou Q; He Q; La Z; Yang L; Hu Y
J Zhejiang Univ Sci B; 2009 May; 10(5):331-40. PubMed ID: 19434759
[TBL] [Abstract][Full Text] [Related]
13. The application of gene therapy in China.
Peng Z; Yu Q; Bao L
IDrugs; 2008 May; 11(5):346-50. PubMed ID: 18465676
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic Viruses for Tumor Precision Imaging and Radiotherapy.
Wu ZJ; Tang FR; Ma ZW; Peng XC; Xiang Y; Zhang Y; Kang J; Ji J; Liu XQ; Wang XW; Xin HW; Ren BX
Hum Gene Ther; 2018 Feb; 29(2):204-222. PubMed ID: 29179583
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Adenovirus-p53 Gene Therapy for Advanced Unresectable Soft-Tissue Sarcomas.
Xiao SW; Xu YZ; Xiao BF; Jiang J; Liu CQ; Fang ZW; Li DM; Li XF; Cai Y; Li YH; Sun Y; Su X; Zhu GY; Zhang SW
Hum Gene Ther; 2018 Jun; 29(6):699-707. PubMed ID: 29284287
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
Horowitz J
Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
[TBL] [Abstract][Full Text] [Related]
17. Recombinant adenovirus p53 combined with radiotherapy improves efficacy and safety in the treatment of head and neck lymphoma.
Xu YH; Liu SH; Hao FR; Zhang YH
Cancer Biomark; 2018; 23(2):213-220. PubMed ID: 30198865
[TBL] [Abstract][Full Text] [Related]
18. Effect and Safety of Recombinant Adenovirus-p53 Transfer Combined with Radiotherapy on Long-Term Survival of Locally Advanced Cervical Cancer.
Su X; Chen WJ; Xiao SW; Li XF; Xu G; Pan JJ; Zhang SW
Hum Gene Ther; 2016 Dec; 27(12):1008-1014. PubMed ID: 27575731
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer.
Qu H; Xia Y; Li X
Curr Gene Ther; 2020; 20(4):313-320. PubMed ID: 32851960
[TBL] [Abstract][Full Text] [Related]
20. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models.
Nielsen LL; Gurnani M; Syed J; Dell J; Hartman B; Cartwright M; Johnson RC
Hum Gene Ther; 1998 Mar; 9(5):681-94. PubMed ID: 9551616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
